Biologics
-
Biologics | Large Joint
'Cell-Sheet Accelerating Technology' Offers Promising Treatment for Knee Arthritis
An approach combining conventional surgery and chondrocyte cell-sheet transplantation is a promising therapy for OA of the knee.PR Newswire 03.25.19
-
Biologics
Disrupting the Ceramic Bone Graft Substitute Sector
NuVasive's AttraX drives increased bone formation, faster fusion than traditional ceramic bone grafts.Online Exclusives Michael Barbella, Managing Editor 03.21.19
-
Biologics
MTF Biologics Introduces CartiMax Viable Cartilage Allograft
New putty-like tissue form designed to easily fill cartilage lesions in the knee, foot and ankle.MTF Biologics 03.20.19
-
Biologics
Biologics' Backbone
The explosion in spinal fusion procedures is leading to the development of innovative regenerative treatments.Online Exclusives Michael Barbella 03.18.19
-
Biologics
Unconventional Solutions
Seed Biotech developing orthobiologics solutions from 'alternative sources.'Online Exclusives Michael Barbella, Managing Editor 03.15.19
-
Biologics
AAOS News: Fidia Pharma USA Introduces NuDYN Allograft
NuDYN is the first product in Fidia’s new Orthobiologics portfolio; a novel acellular amnion-derived injectable allograft.Fidia Pharma USA 03.13.19
-
Biologics
Smith & Nephew Acquires Osiris Therapeutics for $660M
Osiris makes regenerative medicine products, including skin, bone graft, and articular cartilage substitutes.PR Newswire 03.12.19
-
Biologics
Orthobiologics' Precious Balance
Harmonizing patient outcomes, long-term safety/efficacy, and costs is the secret to success in the orthobiologics market.Online Exclusives Michael Barbella, Managing Editor 03.12.19
-
Biologics
Orthobiologics' High Reward
Demand for regenerative treatments is fueling growth in the sector, but the high cost of these therapies could curb overall market expansion.Online Exclusives Michael Barbella, Managing Editor 03.07.19
-
Biologics
Myoscience to be Acquired by Pacira
The company’s iovera° system offers targeted, long-lasting non-opioid pain management.Business Wire 03.05.19
-
Biologics
Natural Selection: Biologics in Orthopedics
With their healing prowess and cost-effectiveness, stem cells and bone graft substitutes are increasingly gaining traction in the orthobiologics sector.Michael Barbella, Managing Editor 02.13.19
-
3-D Printing/Additive Mfg. | Biologics | MIS/Robotics
Getting a Clinical Viewpoint
Last year, at the North American Spine Society’s (NASS) 33rd Annual Meeting, held in Los Angeles, Jeffrey C. Wang, M.D., professor of orthopaedic surgery and neurological surgery (clinical scholar) at the Keck Medical Center at the University o…Sean Fenske, Editor-in-Chief 02.13.19
-
Biologics
Biogennix Names Chief Financial Officer
New hire has over 25 years of professional finance experience.Biogennix 02.06.19
-
Biologics
Bioventus Launches DUROLANE in Malaysia
Company selects Athrotech as exclusive distribution partner for the product.Bioventus 01.29.19
-
Biologics | Materials
Scientists Make Strides in Creation of Clinical-Grade Bone
Research team finds that mesenchymal progenitors can be grown without the use of animal-derived compounds.New York Stem Cell Institute 01.16.19
-
Biologics | Spine/Neurology
3D Printed Implant Promotes Nerve Cell Growth to Treat Spinal Cord Injury
The novel scaffolding mimicked natural anatomy and boosted stem cell-based treatment.University of California - San Diego 01.14.19
-
Biologics | MIS/Robotics | Trauma/Sports
Global Prospects in Orthopedics
Camil Moldoveanu was fully prepared for the challenge. Or so he thought. The four-time Brazilian jiu-jitsu world champion knew he would need significant rehabilitation for his knee injury. He also knew the recovery process would be difficult, and…Michael Barbella, Managing Editor 11.30.18
-
3-D Printing/Additive Mfg. | Biologics | Materials
Regrowing Long Bone Segments Using 3D Printing
3D printed scaffolds—plastic bone-shaped frames—could replace large, missing, or broken bone segments.University of Arizona Health Sciences 11.27.18
-
Biologics | Materials
Citrate-Based Biomaterial Fuels Bone Healing with Less Rejection
Slow-release, biodegradable, citrate-releasing scaffolds could act as bone-growth templates to speed healing.Penn State 11.27.18
-
Biologics
Bioventus Names Former DuPont Executive to its Board of Managers
New board member spent nearly 40 years at global chemical company.Business Wire 10.29.18
